MetaCap

Aptevo Therapeutics (APVO) vs Capstone (CAPS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Aptevo Therapeutics is the larger company by market cap ($1.4 million vs $1.3 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

APVO-78.04%CAPS+927.84%
+2020%+921%-178%
Oct 7, 20261 yearNov 20, 2026
APVO-77.42%CAPS+949.56%
+1881%+855%-171%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

APVO versus CAPS key metrics
MetricAPVOCAPS
Share price$0.4041$1.44
Market cap$1.40M$1.35M
1-day change-2.37%-9.15%
P/E ratio (TTM)0.01—
EPS (TTM)$66.96$-89.68
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$46.88M
Revenue growth (YoY)—+4.47%
Net income (latest FY)$-25.97M$-21.23M
Gross margin—23.02%
Operating margin—-23.43%
Net margin—-45.28%
52-week high$25.56$28.50
52-week low$0.377$1.42
Distance from 52-week high-98.42%-94.95%
Analyst consensusnonenone
Avg. price target upside+6210.32%+108.33%
Average volume132.90K153.70K
Shares outstanding3.46M935.38K
Employees3393
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Aptevo Therapeutics

APVO stock →

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.

Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees

About Capstone

CAPS stock →

Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.

Health Care · Biotechnology: Pharmaceutical Preparations · 93 employees

APVO vs CAPS FAQ

Which is bigger, Aptevo Therapeutics or Capstone?

Aptevo Therapeutics (APVO) is larger, with a market capitalization of $1.40M compared with $1.35M for Capstone (CAPS).

Are Aptevo Therapeutics and Capstone in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons